NAM
VOR icon

Nexpoint Asset Management’s Vor Biopharma VOR Stock Holding History

Nexpoint Asset Management’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,500
Closed -$933K – 205
2021
Q2 		$933K Buy
+2,500
New +$1.23M 0.2% 70

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Nexpoint Asset Management's VOR Position: Q3 2021 in Review

Nexpoint Asset Management sold out of Vor Biopharma (VOR) in Q3 2021, closing a stake of 2,500 shares — an estimated $933K sold.

Nexpoint Asset Management first reported a position in VOR in Q2 2021 and held it in 1 quarter. The position peaked at $933K in Q2 2021. 55 funds tracked by Wall St. Rank hold VOR as of Q3 2021.

  • Nexpoint Asset Management reported no remaining Vor Biopharma position as of Q3 2021 after selling out during the quarter.
  • Nexpoint Asset Management sold 2,500 Vor Biopharma shares in Q3 2021, an estimated $933K.
  • Nexpoint Asset Management first reported a position in Vor Biopharma in Q2 2021 and held it in 1 quarter.
  • Nexpoint Asset Management's Vor Biopharma position peaked at $933K in Q2 2021.
  • 55 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2021.

Based on Nexpoint Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.